Sigyn Therapeutics, Inc. (SIGY)
USD 3.15
(0.0%)
USD 3.15
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -1.38 Million | -1.83 Million | -1.77 Million | -829.8 Thousand | -143.68 Thousand | -286.11 Thousand |
| Net Income | -4.14 Million | -2.92 Million | -3 Million | -1.25 Million | -3.33 Million | -2.62 Million |
| Depreciation & Amortization | 8856.00 | 10.45 Thousand | 19.15 Thousand | 11.3 Thousand | 75.32 Thousand | 247.38 Thousand |
| Deferred income taxes | -352.96 Thousand | - | -249.10 | - | -260 Thousand | 946.93 Thousand |
| Stock-based compensation | 215.55 Thousand | - | 249.1 Thousand | - | 3840.00 | 10.13 Thousand |
| Change in working capital | 850.09 Thousand | 307 Thousand | -34.14 Thousand | 75.32 Thousand | 348.96 Thousand | 545.22 Thousand |
| Other non-cash items | 2.04 Million | 782.11 Thousand | 1.24 Million | 343.15 Thousand | 2.76 Million | 584.48 Thousand |
| Investing Cash Flow | - | -860.00 | -29.26 Thousand | -10.79 Thousand | 100 Thousand | -8452.00 |
| Investments in PPE | - | -860.00 | -29.26 Thousand | -10.79 Thousand | - | -8452.00 |
| Acquisitions | - | - | - | - | 100 Thousand | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | -10.80 | 100 Thousand | -8452.00 |
| Financing Cash Flow | 1.38 Million | 1.49 Million | 2.06 Million | 925.01 Thousand | 36.68 Thousand | 292.46 Thousand |
| Debt repayment | -1.31 Million | -1.56 Million | -55 Thousand | -925.01 Thousand | -33.33 Thousand | -112.55 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1.52 Million | 145.1 Thousand | 1.86 Million | 396 Thousand | - | 205.76 Thousand |
| Other Financing Activities | 1.17 Million | 2.92 Million | 250 Thousand | 1.45 Million | 70.02 Thousand | 199.25 Thousand |
| Accounts receivables | - | - | - | - | -34.29 Thousand | 7634.00 |
| Accounts payables | 196.62 Thousand | 287.84 Thousand | 23.66 Thousand | 15.09 Thousand | -12.22 Thousand | -138.8 Thousand |
| Inventory | - | - | - | - | 135.48 Thousand | 2545.00 |
| Other working capital | 653.46 Thousand | 19.16 Thousand | -57.81 Thousand | 60.23 Thousand | 260 Thousand | 673.84 Thousand |
| Cash at beginning of period | 8356.00 | 340.95 Thousand | 84.4 Thousand | - | 7497.00 | 9592.00 |
| Cash at end of period | 11.69 Thousand | 8356.00 | 340.95 Thousand | 84.4 Thousand | 500.00 | 7497.00 |
| Capital Expenditure | - | -860.00 | -29.26 Thousand | -10.79 Thousand | - | -8452.00 |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 3334.00 | -332.6 Thousand | 256.55 Thousand | 84.4 Thousand | -6997.00 | -2095.00 |
| Free Cash Flow | -1.38 Million | -1.83 Million | -1.8 Million | -840.6 Thousand | -143.68 Thousand | -294.56 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -862.38 Thousand | -758.08 Thousand | -4.14 Million | -1.17 Million | -905.72 Thousand | -723.12 Thousand |
| Depreciation & Amortization | 1364.00 | 1523.00 | 8856.00 | 1610.00 | 2016.00 | 2615.00 |
| Deferred income taxes | - | - | -352.96 Thousand | -126.03 Thousand | -2567.00 | -208.55 Thousand |
| Stock-based compensation | 37.5 Thousand | 37.5 Thousand | 215.55 Thousand | 103.05 Thousand | 37.5 Thousand | 37.5 Thousand |
| Change in working capital | 381.71 Thousand | 356.84 Thousand | 850.09 Thousand | 484.77 Thousand | 239.91 Thousand | 205.69 Thousand |
| Other non-cash items | 340.32 Thousand | 99.34 Thousand | 2.04 Million | 584.74 Thousand | 264.8 Thousand | 357.18 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | 4.00 | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 203.6 Thousand | 256.76 Thousand | 1.38 Million | 75 Thousand | 405 Thousand | 30 Thousand |
| Debt repayment | -218.6 Thousand | -251.75 Thousand | -1.31 Million | -40 Thousand | -390 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 1.52 Million | 1.52 Million | - | - |
| Other Financing Activities | -15 Thousand | 5000.00 | 1.17 Million | 115 Thousand | 795 Thousand | 30 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -41.08 Thousand | 67.8 Thousand | 196.62 Thousand | 162.51 Thousand | 21.68 Thousand | 74.85 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 422.8 Thousand | 289.04 Thousand | 653.46 Thousand | 322.25 Thousand | 218.23 Thousand | 130.83 Thousand |
| Cash at beginning of period | 32.83 Thousand | 11.69 Thousand | 8356.00 | 64.58 Thousand | 23.63 Thousand | 322.32 Thousand |
| Cash at end of period | 53.64 Thousand | 32.83 Thousand | 11.69 Thousand | 11.69 Thousand | 64.58 Thousand | 23.63 Thousand |
| Capital Expenditure | 4.00 | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 20.8 Thousand | 21.14 Thousand | 3334.00 | -52.89 Thousand | 40.95 Thousand | -298.69 Thousand |
| Free Cash Flow | -182.79 Thousand | -235.61 Thousand | -1.38 Million | -127.89 Thousand | -364.04 Thousand | -328.69 Thousand |
IVZ
HUDCO
002614
600095
TYRA
300628